Evidence map›Paper›PMID 31759672›Full record

ArticleJournal of affective disorders2020

Treating depressive disorders with the Unified Protocol: A preliminary randomized evaluation.

Shannon Sauer-Zavala, Kate H Bentley, Stephanie Jarvi Steele, Julianne Wilner Tirpak, Amantia A Ametaj, Maya Nauphal, Nicole Cardona, Mengxing Wang, Todd J Farchione, David H Barlow

Abstract read
In one paragraph

Article in Journal of affective disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2022
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shannon Sauer-ZavalaDepartment of Psychology, University of Kentucky, Lexington, KY, U.S.A. Electronic address: ssz@uky.edu.
Kate H BentleyDepartment of Psychological and Brain Sciences, Boston University, Boston, MA, U.S.A.
Stephanie Jarvi SteeleDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.
Julianne Wilner TirpakDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.
Amantia A AmetajDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.
Maya NauphalDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.
Nicole CardonaDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.
Mengxing WangDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.
Todd J FarchioneDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.
David H BarlowDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, U.S.A.

Funding

Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety DisordersR01MH090053 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI BARLOW, DAVID H. · 2011 to 2015
$2.9M
NIMH NIH HHS R01 MH090053
6 · The paper itself

Abstract

objectivesThis study aims to examine the efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) for individuals diagnosed with a depressive disorder.

methodParticipants included 44 adults who met criteria for major depressive disorder, persistent depressive disorder, or another specified depressive disorder according to the Anxiety Disorder Interview Schedule (ADIS). These individuals represent a subset of patients from a larger clinical trial comparing the UP to single-disorder protocols (SDPs) for discrete anxiety disorders and a waitlist control (WLC) condition (Barlow et al., 2017); inclusion criteria for the parent study required participants to have a principal anxiety disorder.

resultsSignificant reductions in depressive symptoms were observed within the UP condition across clinician-rated and self-report measures of depression from baseline to post-treatment, as well as to the 12-month follow-up assessment. Compared to the WLC group, individuals in the UP condition demonstrated significantly lower levels on our continuous, clinician-rated measure of depressive symptoms at post-treatment. There were no differences between the UP and SDP conditions on depressive symptoms at post-treatment or at the 12-month follow-up timepoint.

conclusionsIn this exploratory set of analyses, the UP evidenced efficacy for reduction of depressive symptoms, adding to the growing support for its utility in treating depression.

Indexed as

Cognitive Behavioral TherapyMajor Depressive DisorderAdultAnxiety DisordersHumansMood DisordersTreatment OutcomeDepressionTransdiagnostic treatmentUnified Protocol

Identifiers

PMID31759672
PMCPMC7024024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.